Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ETRA

Electra Therapeutics (ETRA) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $9.04 -1.1% on the day -31.8% over 12 months 52-week range $9.04 – $13.92

Share price and insider trades

ETRA closeInsider buyInsider sale
8101214OctBought $39,999,990 on 2026-09-21 · Carl L Gordon, Orbimed Capital Gp Vii Llc
Bought, 12 months$40.0M
Sold, 12 months$0
Insiders buying2
Insiders selling0

Electra Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $40.0M and 0 sold $0 of ETRA stock on the open market.

ETRA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $40.0M bought (4 trades)$40.0MQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$40.0M4—0

Valuation, profit and volume

Pick score 51/100
P/E (trailing)n/aSector median 24.7
Market value$567MBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day—Last 5 sessions
Insiders' paper profit−$15.9MOn all tracked purchases -39.7%

Summary

Over the past 12 months, 2 Electra Therapeutics, Inc. insiders reported open-market purchases totaling $40.0M, while 0 insiders reported sales totaling $0.

ETRA stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 23SEC Carl L GordonDirector Buy 1,000,0001,758,279 held (+132%) $15.00 $15.0M -39.7% —
Sep 23SEC Orbimed Capital Gp Vii LlcDirector Buy 1,000,0001,758,279 held (+132%) $15.00 $15.0M -39.7% —
Sep 23SEC Carl L GordonDirector Buy 333,3335,126,891 held (+7%) $15.00 $5.0M -39.7% —
Sep 23SEC Orbimed Capital Gp Vii LlcDirector Buy 333,3335,126,891 held (+7%) $15.00 $5.0M -39.7% —

Insiders at Electra Therapeutics, Inc.

InsiderBoughtSoldLast filingScore
Carl L GordonDirector $20.0M — Sep 23, 2026 —
Orbimed Capital Gp Vii LlcDirector $20.0M — Sep 23, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

ETRA stock: common questions

Are Electra Therapeutics, Inc. insiders buying ETRA stock?

In the past 12 months, 2 insiders reported open-market purchases of ETRA worth $40.0M. The latest was Director Carl L Gordon bought $15.0M of ETRA at $15.00 — largest purchase by this insider in our records; raises the stake by 132%.

Are Electra Therapeutics, Inc. insiders selling ETRA stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ETRA's 52-week range?

Over the past year ETRA has traded between $9.04 and $13.92. It last closed at $9.04 on Oct 9, 2026.